메뉴 건너뛰기




Volumn 20, Issue SUPPL. 1, 2001, Pages

Developing vaccines involving new technologies to ensure safety and timely licensure: The industry perspective

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; NUCLEIC ACID; VACCINE;

EID: 0035888296     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00297-3     Document Type: Article
Times cited : (2)

References (14)
  • 4
    • 0033960454 scopus 로고    scopus 로고
    • Immunological hazards associated with vaccination of humans
    • (2000) J Autoimmun , vol.14 , pp. 11-13
    • Rose, N.R.1
  • 5
    • 0032253348 scopus 로고    scopus 로고
    • Regulatory aspects of clinical trials with vaccines
    • Plotkin S, Brown F, Horaud F, editors. Pre-clinical and clinical development of new vaccines, Basel, Karger
    • (1998) Dev Biol Stand , vol.95 , pp. 69-74
    • Georges, A.M.1
  • 6
    • 0003356748 scopus 로고    scopus 로고
    • note
  • 10
    • 0032239634 scopus 로고    scopus 로고
    • Experimental challenge studies in the development of vaccines for infectious diseases
    • Plotkin S, Brown F, Horaud F, editors. Pre-clinical and clinical development of new vaccines, Basel, Karger
    • (1998) Dev Biol Stand , vol.95 , pp. 169-174
    • Levine, M.M.1
  • 12
    • 0032864108 scopus 로고    scopus 로고
    • Lessons learned from a review of the development of selected vaccines
    • (1999) Pediatrics , vol.104 , pp. 942-950


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.